DD · DuPont de Nemours

164 filings

DD SEC Filings

DuPont de Nemours - 164 total filings

Filing record · 2017–202610-K910-Q288-K127

Showing 1–50 of 164 filings

DuPont de Nemours 8-K Report, Financial Results (Nov 3, 2026)

DuPont de Nemours, Inc. filed this Form 8-K on November 3, 2026 to furnish a press release (Exhibit 99.1) announcing third quarter 2026 results, which are presented on a continuing operations basis. Net sales were $1,868 million, up 4% from $1,795 million a year earlier, with organic sales up 5% and a 1% currency headwind. GAAP income from continuing operations rose to $171 million from $102 million, and GAAP EPS from continuing operations was $1.24 versus $0.70. Operating EBITDA was $469 million, up 8%, with the margin at 25.1% versus 24.3%. Adjusted EPS was $2.09 compared with $1.29, a 62% increase. Cash provided by operating activities from continuing operations was $410 million, and transaction-adjusted free cash flow was $341 million, representing 121% conversion. During the quarter the company completed a $250 million accelerated share purchase and substantially completed $100 million of open market repurchases, and it announced an intent to repurchase $250 million of shares in the fourth quarter. Management raised full-year 2026 guidance, now expecting net sales of about $7,190 million, operating EBITDA of about $1,785 million, organic growth of about 4.5%, and adjusted EPS of $7.47 to $7.52. The fourth-quarter outlook calls for net sales of about $1,825 million and adjusted EPS of $1.90 to $1.95. Healthcare & Water Technologies and Diversified Industrials each reported 4% organic sales growth in the quarter, although Water Technologies cited continued disruptions in the Middle East.

Nov 3, 2026 10-Q

DuPont de Nemours Quarterly Report for Q3 Ended Sep 30, 2026

DuPont de Nemours, Inc. reported third-quarter 2026 net sales of $1.87 billion, up 4 percent from $1.80 billion in the prior-year quarter, driven by a 5 percent increase in organic sales partially offset by a 1 percent unfavorable currency impact. Income from continuing operations before income taxes rose to $279 million from $91 million, and net income available for common stockholders was $123 million, compared with a loss of $123 million a year earlier. Results were affected by the absence of prior-year transaction-related tax benefits and by discontinued operations, which posted a $45 million loss in the quarter. Operating EBITDA was $505 million for the quarter versus $465 million, with Healthcare & Water Technologies at $263 million and Diversified Industrials at $242 million. For the nine months, net sales were $5.37 billion, up 4 percent, and net income available for common stockholders was $427 million, compared with a loss of $653 million in the prior year. The Aramids Divestiture closed on April 1, 2026, for pre-tax cash proceeds of approximately $1.2 billion plus a $300 million note receivable and an equity interest valued at $325 million in Arclin. Cash and cash equivalents rose to $1.65 billion at September 30, 2026, from $715 million at year-end 2025, and long-term debt was $3.09 billion. The company repurchased shares under its $2B Authorization, paid $243 million in dividends, and plans to repurchase $250 million more in the fourth quarter. The filing also details substantial legacy PFAS-related obligations. The New Jersey settlement carries an aggregate payment of $875 million over 25 years, and the North Carolina settlement provides for $455 million over 15 years, with the company's share of the North Carolina liability at a net present value of $127 million. DuPont's indemnification liabilities total $728 million, and the company states it cannot estimate losses above amounts accrued, so these matters remain a key area of investor attention.

Nov 3, 2026 8-K

DuPont de Nemours 8-K Report, Material Agreement (Sep 10, 2026)

On September 9, 2026, DuPont de Nemours, Inc. entered into a Settlement Agreement with The Chemours Company, Corteva, Inc. and EIDP, Inc., and the State of North Carolina, acting through its Attorney General, along with 11 local government and water authority plaintiffs. The settlement resolves claims relating to PFAS and other emissions from the Fayetteville Works facility, as well as the State's claims of PFAS contamination unrelated to that facility, including contamination associated with aqueous film-forming foam (AFFF). The settlement remains subject to the entry of orders dismissing the covered claims. The settlement includes aggregate cash payments of $455 million to the plaintiffs, payable over 15 years and shared among the companies under the 2021 Memorandum of Understanding (MOU). Of the total, $18 million is attributed to PFAS contamination unrelated to Fayetteville Works, of which no more than $14.4 million, approximately 3 percent, can be ascribed to AFFF. DuPont recorded a probable loss of about $125 million in the second quarter of 2026 within discontinued operations, reflecting the pre-tax net present value of its share of the payments before giving effect to Qnity Electronics Inc.'s obligation to reimburse 44 percent of that share. The companies also agreed to establish a $135 million reserve fund, accessible only if Chemours fails to perform its obligations under its 2019 Consent Order with the State. They further agreed to value the settlement and future settlements at net present value as if payable in equal annual installments over 25 years, discounted at 8 percent, for MOU purposes. Because the New Jersey and North Carolina payments qualify for withdrawal from the MOU escrow account and exceed future escrow contribution obligations, all future escrow contributions, including the one due in September 2026, are considered satisfied.

Sep 10, 2026 10-Q

DuPont de Nemours Quarterly Report for Q2 Ended Jun 30, 2026

DuPont de Nemours, Inc. reported second-quarter 2026 net sales of $1.82 billion, up from $1.75 billion a year earlier, with the filing stating organic sales rose 4 percent. Income from continuing operations before income taxes was $266 million versus $78 million in the prior-year quarter, and net income available for DuPont common stockholders was $143 million, or $1.05 per basic share, compared with $59 million in the year-earlier period. Results for the period include discontinued operations, which posted a loss of $44 million in the quarter, reflecting MOU-related activity and a $125 million North Carolina accrual, partly offset by gains tied to the Aramids Divestiture. The Aramids business was sold to Arclin on April 1, 2026, for pre-tax cash proceeds of approximately $1.2 billion, a $300 million note receivable and a roughly 16 percent equity interest valued at $325 million. Cash and cash equivalents rose to $1.74 billion at June 30, 2026, from $715 million at December 31, 2025, and the company reported $2.9 billion of working capital. Total debt was $3.125 billion, and the company repurchased about $275 million of stock in May under an accelerated share repurchase, with a further $250 million expected in the third quarter. The filing also highlights ongoing PFAS exposure. The company's share of the New Jersey settlement is recorded at a net present value of $188 million, and the AFFF multidistrict litigation includes approximately 12,400 personal injury cases. The company stated it is unable to estimate losses above the amounts accrued, and the 2026 DuPont Restructuring Program anticipates charges of approximately $75 million through 2028.

Aug 4, 2026 8-K

DuPont de Nemours 8-K Report, Financial Results (Aug 4, 2026)

DuPont de Nemours, Inc. reported second quarter 2026 results in an Item 2.02 8-K, furnishing a press release as Exhibit 99.1. Net sales rose 4% to $1,819 million, with organic sales also up 4%. GAAP income from continuing operations was $191 million, compared with $24 million a year earlier, and GAAP EPS from continuing operations was $1.37. Operating EBITDA increased 6% to $448 million, with an operating EBITDA margin of 24.6% versus 24.2%. Adjusted EPS was $1.88 versus $1.27, up 48%. Cash provided by operating activities from continuing operations was $400 million, and capital expenditures were $76 million. Transaction-adjusted free cash flow was $326 million, up from $107 million, representing 127% conversion. The company also announced its intent to repurchase $250 million of shares in the third quarter, and stated that its GICS classification changed to Industrials effective July 31, 2026. DuPont raised its full-year 2026 guidance. Full-year net sales are now expected at $7,160 million to $7,190 million, operating EBITDA at $1,750 million to $1,770 million, and adjusted EPS at $7.17 to $7.32. The CFO stated the operating EBITDA midpoint is approximately $1.76 billion, the adjusted EPS midpoint is $7.24, and organic sales growth is expected to be slightly above 4%, with mid-single digit organic growth expected in the second half. Results are presented on a continuing operations basis following the Aramids divestiture (completed April 1, 2026) and the Electronics separation into Qnity (November 1, 2025), and a 1-for-3 reverse stock split became effective June 24, 2026.

Aug 4, 2026 8-K

DuPont de Nemours 8-K Report, Rights Modification (Jun 24, 2026)

DuPont de Nemours, Inc. filed a Current Report on Form 8-K disclosing that it amended its Third Amended and Restated Certificate of Incorporation to effect a 1-for-3 reverse stock split of its common stock. The Certificate of Amendment was filed with the Delaware Secretary of State on June 23, 2026 and became effective at 12:01 a.m. Eastern Time on June 24, 2026. The amendment also reduced the number of authorized shares of common stock by a corresponding ratio. The reverse split was previously approved by stockholders on May 21, 2026 and by the Board of Directors on May 26, 2026. Following the filing of the Certificate of Amendment, the company filed a restated Third A&R Certificate of Incorporation solely to reflect the amendment, effective at 12:02 a.m. Eastern Time on June 24, 2026. The company's common stock will continue to trade on the New York Stock Exchange under the existing ticker "DD," but under a new CUSIP number of 26614N 201. The filing is largely administrative in nature, as it documents a charter change and a change in the stock's CUSIP rather than any change to operations or financial results. Investors should note that the per-share price and share count will be adjusted by the 1-for-3 ratio, and that the corresponding reduction in authorized shares is reflected in the restated charter, which is attached as Exhibit 3.2.

Jun 24, 2026 8-K

DuPont de Nemours 8-K Report, Shareholder Vote Results (May 26, 2026)

DuPont de Nemours, Inc. reported the results of its 2026 Annual Meeting of Stockholders, held May 21, 2026. Of 409,867,418 shares outstanding and entitled to vote as of the March 30, 2026 record date, 341,319,707 shares were voted, representing 83.27 percent. Stockholders elected all 10 director nominees, approved the advisory resolution on executive compensation with 266,312,481 votes for and 21,105,382 against, and ratified PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026 with 338,791,200 votes for. Stockholders also approved an amendment to the certificate of incorporation to effect a reverse stock split at a ratio of not less than 1-for-2 or not more than 1-for-4, with a corresponding reduction in authorized common shares, by 335,519,752 votes for. On May 26, 2026, the Board of Directors approved a 1-for-3 ratio for the reverse stock split. The company expects the split to become effective at 12:01 a.m. Eastern Time on June 24, 2026, and the Board retains discretion to delay or abandon it. Authorized common shares would decline from 1,666,666,667 to 555,555,556. The filing states that, had the split been implemented as of May 22, 2026, outstanding shares would have fallen from approximately 405,058,202 to approximately 135,019,401, subject to fractional-share adjustments. The company states that the split will not affect any stockholder's proportionate ownership, except for cash payments in lieu of fractional shares. The company reaffirmed its second quarter and full year 2026 guidance for net sales, operating EBITDA and adjusted EPS. Presented on a split-adjusted basis, with a weighted average diluted share count of approximately 137 million shares, adjusted EPS guidance is approximately $1.75 for the second quarter (prior guidance approximately $0.59) and $7.02 to $7.16 for full year 2026 (prior guidance $2.35 to $2.40). The common stock is expected to trade on a split-adjusted basis under the existing ticker DD with a new CUSIP of 26614N 201.

May 26, 2026 10-Q

DuPont de Nemours Quarterly Report for Q1 Ended Mar 31, 2026

DuPont de Nemours, Inc. reported first-quarter 2026 net sales of $1,681 million, up from $1,612 million in the first quarter of 2025, with organic sales up 2 percent and a 2 percent favorable currency impact. Income from continuing operations, net of tax, was $150 million versus $80 million a year earlier. Net income attributable to DuPont common stockholders was $161 million, compared with a loss of $589 million in the prior-year period, which was driven by discontinued operations. Diluted earnings per share were $0.39, versus a loss of $1.40. Operating EBITDA rose in both segments: Healthcare & Water Technologies to $244 million from $223 million, and Diversified Industrials to $200 million from $185 million. The quarter reflects the completion of the Aramids Divestiture to Arclin on April 1, 2026, for pre-tax cash proceeds of approximately $1.2 billion, a $300 million note receivable, and a common equity interest valued at $325 million. The Aramids Business is presented as discontinued operations, and the filing notes a $16 million additional loss from classification to held for sale in the quarter. Cash and cash equivalents were $710 million at March 31, 2026, and total debt was $3,172 million. Cash provided by operating activities from continuing operations was $232 million, compared with $77 million a year earlier. The filing also details ongoing PFAS-related exposure. The New Jersey Settlement, with an aggregate cash payment of $875 million payable over 25 years, awaits further hearing on June 24, 2026. The company reports approximately 11,900 personal injury cases in the AFFF MDL and accrued total environmental-related liabilities of $246 million. The company expects to launch a $275 million accelerated share repurchase under its $2 billion authorization, and it plans a 2026 reverse stock split at a ratio between 1-for-2 and 1-for-4, subject to stockholder approval.

May 5, 2026 8-K

DuPont de Nemours 8-K Report, Financial Results (May 5, 2026)

DuPont de Nemours, Inc. reported first quarter 2026 results on May 5, 2026, per Exhibit 99.1, a press release announcing Q1 2026 results and raising full-year 2026 guidance. Net sales were $1,681 million, up 4% from $1,612 million, with organic sales up 2% and a 2% currency benefit. GAAP income from continuing operations rose to $150 million from $80 million, GAAP EPS from continuing operations was $0.36 versus $0.19, and adjusted EPS was $0.55 versus $0.36. Operating EBITDA was $414 million, up from $360 million, with operating EBITDA margin of 24.6% versus 22.3%. Cash provided by operating activities from continuing operations was $232 million versus $77 million, and transaction-adjusted free cash flow was $147 million versus $8 million. The quarter reflected the April 1, 2026 completion of the sale of the Aramids business to Arclin, a portfolio company of an affiliate of TJC LP, for pre-tax cash proceeds of approximately $1.2 billion, subject to adjustments, plus a $300 million note receivable and a non-controlling equity interest valued at $325 million. The company also announced a $275 million accelerated share repurchase expected to be launched imminently. Segment results were mixed: Healthcare & Water Technologies net sales rose 6% to $806 million with 3% organic growth, while Diversified Industrials net sales rose 3% to $875 million with about flat organic sales, and Building Technologies remained weak. For 2026, the company raised full-year guidance to net sales of $7,155 million to $7,215 million, operating EBITDA of $1,730 million to $1,760 million, and adjusted EPS of $2.35 to $2.40. For the second quarter, it estimates net sales of about $1,800 million, operating EBITDA of about $430 million, and adjusted EPS of about $0.59. The company cited the Aramids transaction interest income benefit as a factor in the raised outlook, and said it is passing through price increases to offset higher input costs related to the Middle East conflict.

May 5, 2026 8-K

DuPont de Nemours 8-K Report, Executive Changes (Apr 15, 2026)

DuPont de Nemours, Inc. filed this Form 8-K under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). The filing reports that on April 13, 2026, Luke Kissam tendered his resignation as a member of the Board of Directors, effective April 14, 2026, in connection with his future appointment as Chief Executive Officer of Corteva, Inc. The filing states that Mr. Kissam's departure is not the result of any disagreement with the Company on any matter relating to its operations, policies or practices. In connection with his resignation, the Board approved a decrease in its size from eleven to ten members. For investors, the filing is a governance notice: it documents a board departure and a reduction in board size, and it does not disclose any operational, financial or strategic developments.

Apr 15, 2026 8-K

DuPont de Nemours 8-K Report, Corporate Update (Mar 18, 2026)

On March 18, 2026, DuPont de Nemours, Inc. (NYSE: DD) announced that it plans to seek stockholder approval for an amendment to its Third Amended and Restated Certificate of Incorporation that would authorize a reverse stock split of its common stock. The ratio would be not less than 1-for-2 or more than 1-for-4, with the exact ratio to be set by the Board of Directors at a later date. The Board would have discretion over whether to effect the split, and may delay or abandon it at any time before it becomes effective if it determines the split is no longer in the best interests of the Company or its stockholders. The filing states that, if effected, the split would be accompanied by a corresponding reduction in the number of authorized shares of common stock, and that it would have no impact on stockholders' voting and other rights, on the Company's business operations, or on its outstanding indebtedness. Approval would be sought at the Annual Meeting of Stockholders on May 21, 2026, with a record date of March 30, 2026. Meeting details will follow in preliminary proxy materials to be filed with the SEC. For investors, the key takeaway is that this is a proposal, not a completed action. No ratio has been chosen, stockholder approval has not yet been obtained, and the Board retains full discretion over timing and whether to proceed. The filing does not state a reason for the proposed split.

Mar 18, 2026 8-K

DuPont de Nemours 8-K Report, Regulation FD Disclosure (Mar 16, 2026)

DuPont de Nemours, Inc., a Delaware corporation, filed this Current Report under Item 7.01 (Regulation FD Disclosure) on March 16, 2026 to state that it expects to close the previously announced sale of its aramids business (Kevlar® and Nomex®) to Arclin on April 1, 2026. The filing states that all regulatory conditions to close the sale were satisfied as of March 10, 2026. Arclin is identified in the filing as ARC Falcon Holdings, L.P. and New Arclin U.S. Holding Corp., a wholly-owned subsidiary of Holdings. The filing is informational and furnished rather than filed for Section 18 purposes. It does not provide financial results, purchase price, or other financial figures. The forward-looking statements caution that closing remains subject to the parties' ability to meet the timing and other conditions of the transaction, and it notes DuPont's ownership of a minority interest in the future Arclin company, whose effect on DuPont's results of operations is a stated risk factor. For investors, the key takeaway is that the aramids divestiture is expected to close on April 1, 2026, with regulatory approvals already obtained. The filing does not describe the transaction's financial terms or expected proceeds.

Mar 16, 2026 10-K

DuPont de Nemours Annual Report, Year Ended Dec 31, 2025

DuPont de Nemours, Inc. reported 2025 net sales of $6.8 billion, up 2 percent from $6.7 billion in 2024, driven by a 3 percent increase in volume partially offset by a 1 percent decrease in local price and product mix. Following the November 1, 2025 spinoff of Qnity Electronics, the Electronics Business and the Aramids Business are reported as discontinued operations, so the company's continuing results now consist of two segments: Healthcare & Water Technologies (net sales of $3.23 billion, Operating EBITDA of $972 million, up 15 percent) and Diversified Industrials (net sales of $3.62 billion, Operating EBITDA of $800 million, down 5 percent). Net income available to common stockholders was a loss of $779 million in 2025, driven by a $836 million loss from discontinued operations, including a $768 million goodwill impairment and a $444 million loss on classification of the Aramids business as held for sale. Income from continuing operations was $98 million. Balance sheet and capital allocation changed significantly. Total debt fell to $3.2 billion from $7.2 billion at year-end 2024, and cash and cash equivalents were $715 million. Qnity paid DuPont a cash distribution of approximately $4.1 billion in connection with the separation, which funded debt repayments and the $500 million accelerated share repurchase under a new $2 billion authorization. Dividends paid were $1.43 per share in 2025. Credit ratings at January 31, 2026 were BBB+ (S&P), Baa1 (Moody's) and BBB+ (Fitch), all stable. Looking ahead, the pending sale of the Aramids business to Arclin, a TJC affiliate, is expected to close around the end of the first quarter 2026, with pre-tax cash proceeds of approximately $1.2 billion, a $300 million note receivable and an equity interest valued at $325 million. On February 13, 2026, the company committed to a cost-reduction plan expected to incur $100 million to $150 million of pre-tax restructuring and other costs from 2026 through 2028. For 2026, the company expects growth in Healthcare and Water, about flat Building Technologies, low-single-digit growth in Industrial Technologies, and capital expenditures of about $320 million.

Feb 17, 2026 8-K

DuPont de Nemours 8-K Report, Financial Results (Feb 10, 2026)

DuPont de Nemours, Inc. reported fourth quarter and full year 2025 results on February 10, 2026, with continuing operations now reflecting the Electronics and Aramids businesses as discontinued operations. Fourth quarter net sales were $1,693 million, flat year over year, with organic sales down 1%; GAAP loss from continuing operations was $(108) million, against $(291) million a year earlier, and adjusted EPS was $0.46 versus $0.39. Operating EBITDA rose to $409 million from $395 million, with margin of 24.2%. Fourth quarter net sales included an approximately $30 million headwind from order timing shifted into the third quarter tied to electronics separation system cut-over activities. For full year 2025, net sales increased 2% to $6,849 million and organic sales grew 2%. GAAP income from continuing operations was $98 million, compared with a loss of $(96) million in 2024, and adjusted EPS rose 16% to $1.68. Operating EBITDA increased to $1,628 million, and transaction-adjusted free cash flow was $689 million, up from $587 million, though cash provided by operating activities from continuing operations declined to $560 million from $765 million. Healthcare & Water Technologies drove growth, with full-year net sales up 9% and operating EBITDA up 15%, while Diversified Industrials net sales fell 3% and operating EBITDA fell 5%. For 2026, the company guided to full-year net sales of $7,075 million to $7,135 million, operating EBITDA of $1,725 million to $1,755 million, and adjusted EPS of $2.25 to $2.30, and first-quarter 2026 guidance of approximately $1,670 million in net sales, $395 million in operating EBITDA and $0.48 in adjusted EPS. The filing notes the aramids divestiture to Arclin, a TJC affiliate portfolio company, is expected to close around the end of the first quarter 2026, for pre-tax cash proceeds of approximately $1.2 billion.

Feb 10, 2026 8-K

DuPont de Nemours 8-K Report, Executive Changes (Jan 20, 2026)

DuPont de Nemours, Inc. announced on January 20, 2026 that it has appointed D.G. Macpherson to its Board of Directors, effective immediately. The Board determined Mr. Macpherson is an independent director under New York Stock Exchange listing standards, SEC rules, and the Company's Corporate Governance Guidelines. He is currently Chief Executive Officer and Chairman of W.W. Grainger, Inc., a broad-line distributor of MRO products and services, a role he has held since 2016 as CEO and since 2017 as Chairman. He is 58 years old. The filing states there is no arrangement or understanding between the Company and Mr. Macpherson under which he was selected as a director, and no related-party transactions under Item 404(a) of Regulation S-K. He will receive the Company's standard compensation for non-employee directors. The filing does not disclose any financial results, guidance, or other operating information. The announcement is accompanied by Exhibit 99.1, a press release in which CEO Lori Koch welcomed Mr. Macpherson and cited his experience in operational excellence, supply chain optimization, and business transformation. The press release also notes that he previously served on the International Paper Company Board of Directors from 2021 to 2024.

Jan 20, 2026 8-K

DuPont de Nemours 8-K Report, Corporate Update (Dec 4, 2025)

DuPont de Nemours, Inc., a Delaware corporation ("DuPont"), disclosed in this Form 8-K (Item 8.01, Other Events) that it and Qnity Electronics, Inc. ("Qnity") determined on December 2, 2025, pursuant to the Separation and Distribution Agreement dated November 1, 2025, that the Applicable Percentage of DuPont is 56% and the Applicable Percentage of Qnity is 44%. The filing states that these percentages were determined following the spin-off of Qnity on November 1, 2025. The Applicable Percentage determination resets the Minimum EBITDA in respect of DuPont, as defined in a June 1, 2019 Letter Agreement between DuPont (f/k/a DowDuPont Inc.) and Corteva, Inc., to $1,400,000,000. The filing states that DuPont had indicated in its November 3, 2025 Current Report on Form 8-K that it would disclose this numeric percentage and resulting Minimum EBITDA once determined. For investors, the key takeaways are the allocation of 56% to DuPont and 44% to Qnity under the Separation Agreement and the resulting $1.4 billion Minimum EBITDA reset for DuPont under the Corteva letter agreement. The filing does not describe further operational or financial effects.

Dec 4, 2025 8-K

DuPont de Nemours 8-K Report, Material Agreement (Nov 19, 2025)

DuPont de Nemours, Inc. reported that its consent solicitations for the 5.319% Notes due 2038 and 5.419% Notes due 2048 succeeded. The requisite consents were received by the November 7, 2025 expiration date, and a Fifth Supplemental Indenture dated November 7, 2025 became operative on November 19, 2025. The amendments were made to the indentures governing each series of the Notes, with U.S. Bank Trust Company, National Association serving as trustee. Separately, DuPont announced early results of its tender offer for up to $739,256,000 aggregate principal amount of its 5.419% Notes due 2048, subject to proration. Of the $1,855,219,000 of these notes outstanding, $936,618,000 were validly tendered at or prior to the November 17, 2025 early tender date. Because tenders exceeded the maximum amount, DuPont accepted $739,256,000 on a prorated basis, using an approximate proration factor of 78.9627%. Holders whose notes were accepted receive $1,000 per $1,000 principal amount plus accrued interest. DuPont paid for the accepted notes on November 19, 2025, and the offer remains open until December 3, 2025 unless extended or terminated. DuPont stated that, after completing the tender offer, it will repay its 4.493% Notes due 2025 at maturity and complete a special mandatory redemption of $900,000,000 of 4.725% Notes due 2028, $225,963,000 of 5.319% Notes due 2038, and $294,781,000 of 5.419% Notes due 2048, all issued on October 2, 2025. DuPont said these steps will achieve its intended post-Electronics separation capital structure by repaying approximately $4.0 billion of senior notes in aggregate principal amount.

Nov 19, 2025 8-K

DuPont de Nemours 8-K Report, Financial Results (Nov 6, 2025)

DuPont de Nemours, Inc. reported third quarter 2025 results on November 6, 2025, presented on a continuing operations basis with the Aramids business shown as discontinued operations. Net sales were $3,072 million, up 7% from $2,862 million a year earlier, with organic sales up 6%. Operating EBITDA rose 6% to $840 million, and GAAP income from continuing operations fell 32% to $308 million, reflecting higher separation transaction costs ($139 million of acquisition, integration and separation costs in the quarter) and the absence of prior-year interest rate swap gains. GAAP EPS from continuing operations was $0.70 versus $1.06, while adjusted EPS was flat at $1.09. The company completed the separation of its Electronics business into Qnity Electronics, Inc., with the distribution to stockholders on November 1, 2025. Management raised full-year 2025 guidance for the new DuPont, with operating EBITDA now expected at about $1.6 billion (up from about $1.575 billion) and adjusted EPS at about $1.66. Full-year net sales guidance was trimmed to about $6,840 million from about $6,865 million, which the filing attributes to a lower-than-expected currency tailwind. Capital allocation was the headline announcement. The Board approved a share repurchase authorization of up to $2 billion, with a $500 million accelerated share repurchase expected to launch imminently, and declared a quarterly dividend of $0.20 per share payable December 15, 2025 to holders of record on November 28, 2025. Transaction-adjusted free cash flow was $576 million in the quarter, and the Aramids divestiture to TJC LP is expected to close in the first quarter of 2026.

Nov 6, 2025 10-Q

DuPont de Nemours Quarterly Report for Q3 Ended Sep 30, 2025

DuPont de Nemours, Inc. reported third-quarter 2025 net sales of $3.07 billion, up 7 percent from $2.86 billion a year earlier, driven by a 7 percent volume increase, with ElectronicsCo volume up 11 percent and IndustrialsCo volume up 5 percent. Income from continuing operations, net of tax, was $308 million versus $453 million in the prior-year quarter, and the company posted a net loss of $107 million ($(123) million attributable to DuPont common stockholders) against net income of $465 million a year earlier. The loss was driven by $415 million of losses from discontinued operations, including a $437 million loss from classification of the Aramids business as held for sale, and acquisition, integration and separation costs of $139 million tied primarily to the Electronics Separation. Nine-month net loss was $618 million, and cash provided by continuing operations was $1.26 billion versus $1.52 billion a year earlier. The quarter reflects the completion of the Electronics Separation: Qnity Electronics, Inc. was spun off on November 1, 2025, and beginning in the fourth quarter its results will be reported as discontinued operations. The Aramids Divestiture to TJC LP, with cash proceeds of approximately $1.2 billion, a $300 million note and a minority equity interest valued at $325 million, is expected to close in the first quarter of 2026. Total debt rose to $8.90 billion at September 30, 2025 from $7.17 billion, primarily due to the Qnity Notes issued in August 2025, and the company disclosed a proposed New Jersey PFAS settlement with an aggregate cash payment of $875 million payable over 25 years, of which DuPont's share is recorded at a net present value of $311 million. After quarter end, DuPont announced a new $2 billion share repurchase authorization, expects to launch a $500 million accelerated share repurchase, and entered into a transaction support agreement for a tender offer and consent solicitation on its 2038 and 2048 notes. Credit ratings at November 4, 2025 were BBB+ (S&P, stable), Baa1 (Moody's, negative outlook) and BBB+ (Fitch, stable).

Nov 6, 2025 8-K

DuPont de Nemours 8-K Report, Material Agreement (Nov 3, 2025)

On November 1, 2025, DuPont de Nemours, Inc. completed the separation of its Electronics business, Qnity Electronics, Inc., into an independent public company through a pro rata dividend in-kind of Qnity common stock to DuPont shareholders. DuPont has no ownership interest in Qnity following the Effective Time. Qnity common stock began "regular way" trading on the NYSE under the symbol "Q" on November 3, 2025, and DuPont continues to trade under "DD." Shareholders of record as of October 22, 2025 received one Qnity share for every two DuPont shares held, with cash paid in lieu of fractional shares. The companies entered into a set of separation agreements effective November 1, 2025, including a Separation and Distribution Agreement, Tax Matters Agreement, Employee Matters Agreement, Intellectual Property Cross-License Agreement, Transition Services Agreements, and a Legacy Liabilities Assignment Agreement, under which Qnity is allocated its applicable percentage of certain legacy liabilities and funding obligations and will indemnify DuPont for them. Leadership changed as well. Directors Terrence R. Curtin, Kristina M. Johnson and Steven M. Sterin resigned, and the board was reduced from thirteen to ten members. Edward D. Breen stepped down as Executive Chairman but remains Chairman in a non-executive role. Jon D. Kemp (President of Electronics) and Michael Goss (Vice President and Controller) resigned, and Jeroen Bloemhard, Beth Ferreira and Madeleine Barber were appointed to the roles of President of Healthcare & Water Technologies, President of Diversified Industrials, and Vice President of Tax, Controller and Chief Accounting Officer, respectively. On the capital structure side, DuPont's special mandatory redemption provisions were triggered under the New Notes issued in its exchange offers, requiring redemption of $900,000,000 of New 2028 Notes, $225,963,000 of New 2038 Notes and $294,781,000 of New 2048 Notes, with holder notice due by November 17, 2025. DuPont also entered a transaction support agreement with holders of 83.90% of the 2038 Notes and 60.25% of the 2048 Notes to support consent solicitations for proposed indenture amendments permitting the separation and the proposed sale of its aramids business, and a tender offer for up to $739,256,000 of 2048 Notes at $1,000 per $1,000 principal amount. The company expects to have repaid approximately $4.0 billion of senior notes, with total refinancing expenses of approximately $168 million.

Nov 3, 2025 8-K

DuPont de Nemours 8-K Report, Exhibit Filing (Nov 3, 2025)

On November 1, 2025, DuPont de Nemours, Inc. completed the separation of its Electronics business into a separate, independent public company, Qnity Electronics, Inc., through a pro rata dividend in-kind of Qnity common stock to DuPont shareholders of record as of October 22, 2025. In connection with the separation, Qnity declared a cash dividend to DuPont of approximately $4.122 billion. This 8-K furnishes unaudited pro forma consolidated financial statements under Article 11 of Regulation S-X (Exhibit 99.1) giving effect to the separation and related capital structure transactions. The pro forma balance sheet as of June 30, 2025 shows total assets moving from $36,559 million as reported to $22,622 million pro forma, and long-term debt moving from $5,326 million to $3,188 million, while cash and cash equivalents decline from $1,837 million to $1,016 million. To reshape its capital structure, DuPont issued new notes in October 2025 and entered into a Transaction Support Agreement on November 3, 2025 with holders of $649 million (approximately 83.9%) of its 2038 Notes and $1,118 million (approximately 60.25%) of its 2048 Notes. Those holders agreed to support consent solicitations to amend the indentures to permit the separation and the proposed sale of the aramids business, and to tender $1,029 million of 2048 Notes into a tender offer for up to $739 million at par plus accrued interest. The company states that after these transactions, the special mandatory redemption of the New Notes, and repayment of its 4.493% Notes due 2025, it will have repaid approximately $4.0 billion of senior notes, with total refinancing expenses of approximately $168 million. The pro forma statements do not reflect the pending aramids divestiture to Arclin, which the company agreed to on August 29, 2025. The pro forma statements of operations show net loss from continuing operations attributable to common stockholders of $(539) million for the six months ended June 30, 2025 and net income of $94 million for the year ended December 31, 2024 on a pro forma basis. The filing also states that the Applicable Qnity Percentage, which allocates legacy liabilities, is illustratively 44% and will be determined after the distribution.

Nov 3, 2025 8-K

DuPont de Nemours 8-K Report, Corporate Update (Oct 15, 2025)

DuPont de Nemours, Inc. (NYSE: DD) announced on October 15, 2025 that its Board of Directors approved the previously announced tax-free separation of its Electronics business, Qnity Electronics, Inc. ("Qnity"). To effect the separation, the board declared a pro rata dividend of all outstanding Qnity common stock to DuPont stockholders of record as of the close of business on October 22, 2025, with the distribution expected to be paid on November 1, 2025. Stockholders will receive one share of Qnity common stock for every two shares of DuPont common stock held on the record date, with cash paid in lieu of any fractional shares. Following the distribution, DuPont stockholders will own 100% of Qnity, which will become an independent, publicly traded company. The filing states that the Qnity Board of Directors also declared a cash dividend of approximately $4.122 billion, plus a pre-funded interest deposit of approximately $66 million made by DuPont in connection with debt obligations incurred by Qnity, plus any investment returns on amounts held in escrow for those debt obligations, payable to DuPont. The consummation of the separation and distribution remains subject to the satisfaction or waiver of customary conditions, which DuPont expects will be satisfied by the distribution date. Trading mechanics were also disclosed. The NYSE has authorized the Qnity common stock for listing, with "when-issued" trading (symbol "Q WI") expected to begin October 27, 2025 and end October 31, 2025. Regular-way trading in Qnity under the symbol "Q" is expected to begin November 3, 2025. During October 27 through October 31, 2025, DuPont common stock is expected to trade in two markets: a regular-way market under "DD" (with the right to receive Qnity shares) and an ex-distribution market under "DD WI" (without that right).

Oct 15, 2025 8-K

DuPont de Nemours 8-K Report, Material Agreement (Oct 2, 2025)

DuPont de Nemours, Inc. ("DuPont") completed the settlement of its exchange offers for three series of outstanding notes on October 2, 2025, following the expiration of the offers at 5:00 p.m. New York City time on September 30, 2025. Requisite consents were received to adopt the proposed amendments for the 4.725% Notes due 2028, and a Third Supplemental Indenture for those notes became operative on October 2, 2025. Requisite consents were not received for the 5.319% Notes due 2038 or the 5.419% Notes due 2048, so the proposed amendments will not be made to those series. In connection with the settlement, DuPont issued new senior unsecured notes in exchange for tendered existing notes: $1,584,398,000 of New 2028 Notes, $225,963,000 of New 2038 Notes, and $294,781,000 of New 2048 Notes. The new notes carry the same interest rates, interest payment dates, maturity dates and optional redemption provisions as the corresponding existing notes, except that the make-whole methodology follows SIFMA model provisions. Interest on each series is payable on May 15 and November 15, beginning May 15, 2025, with maturities of November 15, 2028, November 15, 2038 and November 15, 2048, respectively. The filing also describes a special mandatory redemption feature. If the Intended Electronics Separation is completed on or before March 31, 2026, DuPont must redeem $900,000,000 of New 2028 Notes, $225,963,000 of New 2038 Notes and $294,781,000 of New 2048 Notes at the greater of a present-value-based make-whole price (using the Treasury Rate plus 25 basis points for the 2028 notes and 30 basis points for the 2038 and 2048 notes) and 100% of principal, plus accrued interest. A registration rights agreement with the dealer managers requires DuPont to use commercially reasonable efforts to register exchange notes, with additional interest payable if the exchange offer is not completed by the 365th day after issuance.

Oct 2, 2025 8-K

DuPont de Nemours 8-K Report, Corporate Update (Sep 16, 2025)

On September 16, 2025, DuPont de Nemours, Inc. (NYSE: DD) announced an amendment to its previously announced offers to exchange any and all of its outstanding 4.725% Notes due 2028 ($2,250,000,000), 5.319% Notes due 2038 ($1,000,000,000) and 5.419% Notes due 2048 ($2,150,000,000) for new notes to be issued by DuPont. Concurrently, DuPont is soliciting consents from eligible holders of each series to adopt proposed amendments to the indentures governing the Existing Notes. The exchange offers and consent solicitations are described in an Offering Memorandum and Consent Solicitation Statement dated September 2, 2025, as supplemented on September 15, 2025. The key change is that, after the Early Participation Date, all tendering holders who tender before the Expiration Date will receive the Total Consideration, which previously was available only to those who tendered by the Early Participation Date. Total Consideration equals $950 principal amount of New Notes plus a $50 principal amount early participation payment in New Notes and $2.50 in cash per $1,000 of Existing Notes. As of 5:00 p.m. New York City time on September 15, 2025, the requisite consents were received for the 2028 Notes, and DuPont executed a supplemental indenture for those notes; the proposed amendments for the 2028 Notes become operative only when the New Notes are issued and the Early Participation Payment is paid on the settlement date. The Exchange Offers are scheduled to expire at 5:00 p.m. New York City time on September 30, 2025, unless extended or terminated. If requisite consents are not received for the 2038 or 2048 Notes, DuPont expects to waive the 50.1% Minimum Tender Condition and accept tendered notes up to sublimits of $400,000,000 (2038 Notes) and $860,000,000 (2048 Notes), subject to proration. Any shortfall relative to the sublimits is expected to be addressed by redeeming up to an equivalent amount of New 2028 Notes and/or outstanding 2028 Notes after the consummation of the Intended Electronics Separation, together with the $900,000,000 special mandatory redemption provisions under the New 2028 Notes. The New Notes have not been registered under the Securities Act.

Sep 16, 2025 8-K

DuPont de Nemours 8-K Report, Regulation FD Disclosure (Sep 3, 2025)

DuPont de Nemours, Inc. (NYSE: DD) filed this Form 8-K on September 3, 2025 to report that it has commenced exchange offers and consent solicitations for three series of its senior notes: 4.725% Notes due 2028, 5.319% Notes due 2038, and 5.419% Notes due 2048. The offers are made in connection with the planned separation of its electronics business, which includes its semiconductor technologies and interconnect solutions businesses, into an independent public company, Qnity Electronics, Inc. The Exchange Offers and Consent Solicitations were announced September 2, 2025, and are made under a confidential offering memorandum dated the same day. Holders who validly tender Existing Notes by the September 15, 2025 Early Participation Date receive $950 principal amount of New Notes plus a $50 principal amount early participation payment and $2.50 in cash per $1,000 tendered. Holders who tender by the September 30, 2025 Expiration Date receive only the $950 principal amount of New Notes. The consent solicitations seek to eliminate substantially all restrictive covenants in the indentures governing the Existing Notes. Completion of each exchange offer requires at least 50.1% of the applicable series to be validly tendered, and the offers are independent of one another. If the Intended Electronics Separation is completed on or before March 31, 2026, DuPont will be required to redeem $900 million of the New 4.725% 2028 Notes, $400 million of the New 5.319% 2038 Notes, and $860 million of the New 5.419% 2048 Notes at a special mandatory redemption price, which is the greater of a make-whole-style present value amount and par, plus accrued interest. The press release targets completion of the separation on November 1, 2025, and states that the separation is not conditioned on the exchange offers or consent solicitations.

Sep 3, 2025 8-K

DuPont de Nemours 8-K Report, Regulation FD Disclosure (Sep 3, 2025)

DuPont de Nemours, Inc. ("DuPont") filed this Form 8-K on September 3, 2025 to furnish excerpts from its Offering Memorandum and Consent Solicitation Statement dated September 2, 2025, tied to exchange offers and consent solicitations for its 4.725% Notes due 2028, 5.319% Notes due 2038 and 5.419% Notes due 2048. The exchange offers seek to swap these Existing Notes for new DuPont notes and, through consent solicitations, eliminate substantially all restrictive covenants in the related indentures. The exhibits cover the intended separation of its Electronics business (semiconductor technologies and interconnect solutions) into Qnity Electronics, Inc., targeted for November 1, 2025, along with recent developments and unaudited pro forma combined financial statements. The separation includes a Qnity Cash Distribution to DuPont of approximately $4.122 billion, funded by Qnity's August 15, 2025 notes issuance ($1.0 billion of 5.750% senior secured notes due 2032 and $750 million of 6.250% senior unsecured notes due 2033) and a planned term loan. The Qnity notes proceeds are held in escrow and subject to special mandatory redemption if the separation is not completed by March 31, 2026. The filing also discloses a pending agreement to sell the aramids business (Kevlar and Nomex) to Arclin for an approximate $1.8 billion valuation, with about $1.2 billion of pre-tax cash proceeds, a $300 million note receivable and a non-controlling equity interest currently valued at $325 million, with completion expected in the first quarter of 2026. For investors, the pro forma statements show the impact of the separation and transactions on DuPont's balance sheet and results. As of June 30, 2025, pro forma short-term borrowings fall to $510 million from $1,849 million as reported, and long-term debt falls to $3,191 million from $5,326 million. The filing states that the Applicable Qnity Percentage, which allocates certain legacy PFAS and other liabilities, is illustratively 44% based on twelve-month June 30, 2025 data, and that the final figure will be determined only after the distribution.

Sep 3, 2025 8-K

DuPont de Nemours 8-K Report, Material Agreement (Sep 2, 2025)

DuPont de Nemours, Inc. (DuPont) has entered into a Transaction Agreement dated August 29, 2025 with ARC Falcon Holdings, L.P. and New Arclin U.S. Holding Corp. (together, Arclin) to sell its Aramids business, which includes Kevlar® and Nomex®. The transaction values the business at approximately $1.8 billion. At closing, DuPont is to receive pre-tax cash proceeds of approximately $1.2 billion, subject to customary transaction adjustments, a $300 million note receivable, and a non-controlling common equity interest in the future Arclin company valued at $325 million, expected to represent an approximate 17.5% stake at closing. Closing is subject to customary conditions, including the absence of certain injunctions and the expiration or termination of Hart-Scott-Rodino waiting periods and certain other approvals, including in the European Union, Japan, China, South Korea and the United Kingdom. Either party may terminate if the transaction is not consummated by May 1, 2026, which may be extended twice by two months each if only regulatory approvals and closing-related conditions remain unsatisfied. The agreement also includes termination rights tied to material breaches or inaccurate representations. The filing also attaches the Transaction Agreement as Exhibit 2.1, with schedules omitted under Item 601(a)(5) of Regulation S-K and certain provisions omitted under Item 601(b)(10)(iv). The forward-looking statements caution highlights risks around timing and completion, the value of the minority interest, and the impact of the transaction on DuPont's results of operations.

Sep 2, 2025 8-K

DuPont de Nemours 8-K Report, Regulation FD Disclosure (Aug 29, 2025)

DuPont de Nemours, Inc. (NYSE: DD) entered into a Transaction Agreement on August 29, 2025 with Arclin, a portfolio company of an affiliate of TJC, L.P., to sell its Aramids business (Kevlar® and Nomex®) in a transaction valuing the business at approximately $1.8 billion. Subject to customary closing conditions, including regulatory approvals, DuPont will receive pre-tax cash proceeds of approximately $1.2 billion, subject to customary transaction adjustments, a $300 million note receivable, and a non-controlling common equity interest in the future Arclin company currently valued at $325 million, expected to represent an approximate 17.5% stake at closing. According to the accompanying press release, the transaction is expected to close in the first quarter of 2026, and Arclin has fully committed financing. Management states the divestiture further streamlines the new DuPont portfolio, enhances its strategic focus, and increases the growth and margin profile, with the cash proceeds at close to be redeployed to drive value creation. The Aramids business, which has about 1,900 employees and five manufacturing sites, generated net sales of $1.3 billion in 2024. The press release also states that the Aramids divestiture will not affect the intended separation of DuPont's electronics business (Qnity), which remains on track for a November 1, 2025 spin-off. The filing notes that the information is furnished under Item 7.01 and is not deemed filed for purposes of Section 18 of the Exchange Act.

Aug 29, 2025 8-K

DuPont de Nemours 8-K Report, Financial Obligation (Aug 15, 2025)

On August 15, 2025, Qnity Electronics, Inc., a wholly-owned subsidiary of DuPont de Nemours, Inc. ("DuPont"), issued $1,000,000,000 of 5.750% senior secured notes due 2032 (the "Secured Notes") and $750,000,000 of 6.250% senior unsecured notes due 2033 (the "Unsecured Notes"). The notes were issued in connection with DuPont's previously announced plan to separate its electronics business through a pro rata distribution of Qnity common stock to DuPont stockholders, with a targeted completion date of November 1, 2025 (the "Spin-Off"). Qnity intends to use the net proceeds, together with borrowings under planned senior secured credit facilities and cash on hand, to fund a cash distribution to DuPont of approximately $4.1 billion plus a pre-funded interest deposit. The gross proceeds and the interest deposit will be held in escrow and released upon completion of the Spin-Off. If the Spin-Off is not consummated by the earlier of March 31, 2026 or the date Qnity notifies the trustees that it will not proceed, or within two business days of escrow release in certain circumstances, the notes will be subject to a special mandatory redemption. Upon the Spin-Off, the notes will be guaranteed by Qnity subsidiaries that are borrowers or guarantors under its credit facilities, and the Secured Notes will be secured by first-priority liens on substantially the same collateral securing those facilities. Both note series carry customary covenants (covering debt, liens, restricted payments, asset sales, affiliate transactions, change of control and mergers) and customary events of default. The Secured Notes may be redeemed before August 15, 2028 at par plus a make-whole premium, and the Unsecured Notes on the same basis; both may be redeemed at specified prices thereafter. Upon certain change-of-control events, Qnity must offer to repurchase each series at 101% of principal.

Aug 15, 2025 8-K

DuPont de Nemours 8-K Report, Regulation FD Disclosure (Aug 12, 2025)

DuPont de Nemours, Inc. (NYSE: DD) filed this Current Report under Item 7.01 (Regulation FD Disclosure) and Item 9.01 to furnish a press release announcing the pricing of debt securities by its wholly-owned subsidiary Qnity Electronics, Inc. Qnity priced $1.0 billion of 5.750% Senior Secured Notes due 2032 and $750.0 million of 6.250% Senior Notes due 2033, each at 100.000% of principal amount. The notes are being issued in connection with DuPont's previously announced plan to separate its electronics business through a pro rata distribution of Qnity common stock to DuPont stockholders (the Spin-Off). The offering was sold under Rule 144A and Regulation S, is expected to close on August 15, 2025, and is not conditioned on completion of the Spin-Off. The gross proceeds will be held in escrow until the Spin-Off is completed. Qnity intends to use the net proceeds, together with borrowings under planned senior secured credit facilities and cash on hand, to fund a cash distribution to DuPont plus a pre-funded interest deposit. Qnity expects a $1.25 billion five-year senior secured revolving credit facility and a $2.35 billion seven-year senior secured term loan facility. The Spin-Off is targeted for November 1, 2025. If it is not consummated by the earlier of March 31, 2026 or the date Qnity notifies the escrow agent and trustee that it will not proceed, or within two business days of release from escrow, the notes are subject to a special mandatory redemption. The filing states the press release is furnished, not filed, for purposes of Section 18 of the Exchange Act. For investors, the key items are the size and terms of the debt that will be assumed by Qnity at separation, the security package on the Secured Notes, and the escrow and special redemption conditions tied to the Spin-Off timeline.

Aug 12, 2025 8-K

DuPont de Nemours 8-K Report, Regulation FD Disclosure (Aug 11, 2025)

DuPont de Nemours, Inc. (NYSE: DD) and its wholly-owned subsidiary Qnity Electronics, Inc. announced on August 11, 2025 that Qnity intends to offer, subject to market and customary conditions, $1.5 billion aggregate principal amount of senior secured notes due 2032 and $1.0 billion aggregate principal amount of senior notes due 2033. The offering is made under Rule 144A and Regulation S and is tied to DuPont's previously announced plan to separate its electronics business through a pro rata distribution of Qnity common stock to DuPont stockholders (the "Spin-Off"). The Notes are to be obligations solely of Qnity as issuer following the Spin-Off. The filing states that the closing of the offering is not conditioned on the Spin-Off. Gross proceeds will be held in escrow and released upon completion of the Spin-Off. Qnity intends to use the net proceeds, together with borrowings under its new senior secured credit facilities and cash on hand, to fund a cash distribution to DuPont plus a pre-funded interest deposit. The Spin-Off is targeted for completion on November 1, 2025. If the Spin-Off is not consummated by the earlier of March 31, 2026 or the date Qnity notifies the escrow agent and trustee that it will not proceed, or within two business days of escrow release, each series of Notes will be subject to a special mandatory redemption. The Secured Notes will be guaranteed on a senior secured basis, and the Unsecured Notes on a senior unsecured basis, by Qnity subsidiaries that are borrowers or guarantors under Qnity's planned senior secured credit facilities. The Secured Notes will be secured by first priority liens on substantially the same collateral securing those facilities. The filing is furnished under Item 7.01 and is not deemed filed for purposes of Section 18 of the Exchange Act.

Aug 11, 2025 8-K

DuPont de Nemours 8-K Report, Financial Results (Aug 5, 2025)

DuPont de Nemours, Inc. reported second quarter 2025 results on August 5, 2025, in a press release furnished as Exhibit 99.1. Net sales were $3,257 million, up 3% from $3,171 million a year earlier, with organic sales up 2% on 4% higher volume partially offset by a 2% decrease in price. GAAP income from continuing operations was $238 million, up from $176 million, and GAAP EPS from continuing operations was $0.54 versus $0.40. Operating EBITDA rose 8% to $859 million, with the operating EBITDA margin at 26.4%, up 120 basis points. Adjusted EPS was $1.12, up 15% from $0.97. Cash provided by operating activities from continuing operations fell 28% to $381 million, while transaction-adjusted free cash flow was $433 million, up 2%, after $168 million of separation-related transaction cost payments and $116 million of capital expenditures. Segment results were mixed: ElectronicsCo net sales rose 6% to $1,170 million with operating EBITDA up 14% to $373 million, and IndustrialsCo net sales rose 1% to $2,087 million with operating EBITDA up 3% to $509 million. The company raised full-year 2025 guidance to net sales of about $12,850 million, operating EBITDA of about $3,360 million and adjusted EPS of about $4.40, and said the guidance incorporates an estimated $20 million (about $0.04 per share) net tariff impact for FY25. The company stated it remains on track for the intended spin-off of its electronics business, Qnity Electronics, Inc., targeted for November 1, 2025. Six-month results included a $768 million goodwill impairment related to the Aramids reporting unit within IndustrialsCo, which drove a six-month loss from continuing operations of $310 million.

Aug 5, 2025 10-Q

DuPont de Nemours Quarterly Report for Q2 Ended Jun 30, 2025

DuPont de Nemours, Inc. reported net sales of $3,257 million for the second quarter of 2025, up from $3,171 million a year earlier, and the filing states this was up 3 percent, driven by a 4 percent increase in volume. Net income available to common stockholders was $59 million, or $0.14 per diluted share, compared with $178 million, or $0.42, in the second quarter of 2024. For the six months, the company posted a net loss available to common stockholders of $530 million, or $(1.27) per diluted share, primarily due to a non-cash goodwill impairment charge of $768 million related to the Aramids reporting unit in the IndustrialsCo segment. Acquisition, integration and separation costs were $154 million in the quarter and $279 million for the six months, mainly tied to the Intended Electronics Separation. The company is targeting November 1, 2025 for the completion of the separation of its Electronics business, which the filing says Qnity Electronics, Inc. is preparing capital structure financing for. Results are now reported in two segments: ElectronicsCo, whose operating EBITDA rose 14 percent in the quarter to $373 million, and IndustrialsCo, whose operating EBITDA rose 3 percent to $509 million. On August 3, 2025, DuPont, Chemours and Corteva agreed to a proposed Judicial Consent Order with the State of New Jersey, carrying an aggregate cash payment of $875 million over 25 years. DuPont's share, with a net present value of $311 million, led to a pre-tax charge of $177 million recorded in discontinued operations, which drove the second-quarter loss from discontinued operations of $168 million. At June 30, 2025, the company reported cash and cash equivalents of $1,837 million, total debt of $7,175 million, and working capital of $2.0 billion. Cash provided by operating activities from continuing operations was $763 million for the six months, down from $1,020 million, reflecting higher working capital needs. The company's credit ratings were BBB+ (S&P, on watch negative), Baa1 (Moody's, negative outlook) and BBB+ (Fitch, on watch negative). The filing also flags tariff and trade-related uncertainty, including the risks tied to China, and notes that the Board declared a third-quarter 2025 dividend of $0.41 per share.

Aug 5, 2025 8-K

DuPont de Nemours 8-K Report, Material Agreement (Aug 4, 2025)

DuPont de Nemours, Inc. (DuPont) reported on its August 4, 2025 Form 8-K that, on August 3, 2025, it, together with The Chemours Company and Corteva Inc. and its subsidiary EIDP Inc., agreed to a proposed Judicial Consent Order with the State of New Jersey to resolve the State's outstanding claims relating to legacy use of substances of concern, including DNAPL, chemical solvents, and PFAS. The settlement is subject to a public notice and comment period and to approval by the Federal District Court of New Jersey (Camden). It resolves legacy claims tied to four historic EIDP operating sites (Chambers Works, Parlin, Pompton Lakes and Repauno), alleged statewide PFAS contamination including from aqueous firefighting foam, fraudulent transfer claims, and known natural resource damages claims. The filing states that DuPont does not admit liability or wrongdoing. The aggregate cash payment to the State is $875 million, payable over 25 years and shared under a 2021 Memorandum of Understanding among Chemours, Corteva and DuPont. DuPont's share is estimated at $311 million, and in the second quarter of 2025 it recorded a pre-tax charge of $177 million within discontinued operations, reflecting the net present value of that share at an 8 percent discount rate. The first annual payment is due within 30 days after the court enters the order, but no earlier than January 31, 2026, and DuPont intends to use $35 million in the MOU Escrow Account for it. The settlement also requires continued remediation at the four sites, a binding third-party review of remedial funding sources that could increase those funds (including at Parlin, for which DuPont is the primary responsible party), and a $475 million Reserve Fund to be established by DuPont and Corteva as secondary financial security. Separately, contingent on court approval, DuPont and Corteva will buy Chemours' interest in future PFAS insurance proceeds by contributing $150 million into an escrow fund, of which DuPont's share is $106.5 million. DuPont's 2025 PFAS MOU escrow funding obligation is suspended until the first settlement payment.

Aug 4, 2025 8-K

DuPont de Nemours 8-K Report, Regulation FD Disclosure (Jul 23, 2025)

DuPont de Nemours, Inc. filed this Current Report under Item 7.01 (Regulation FD Disclosure) to update investors on a regulatory matter involving its Tyvek® business. As previously disclosed in a Form 8-K filed April 4, 2025, the State Administration for Market Regulation of the People's Republic of China (SAMR) had initiated an investigation in connection with the Tyvek® business. On July 22, 2025, SAMR announced that it had suspended the antitrust investigation process. The filing is a limited update with no financial results, guidance, or quantified impact disclosed. The company furnishes the information under Item 7.01, stating that it is not deemed filed for purposes of Section 18 of the Securities Exchange Act and is not incorporated by reference into other filings under the Securities Act or Exchange Act. For investors, the key development is the suspension of the Chinese antitrust investigation affecting Tyvek®, which removes an active regulatory overhang on that business as of the announcement date. The filing does not state whether the suspension is permanent or what conditions may apply to resumption.

Jul 23, 2025 8-K

DuPont de Nemours 8-K Report, Shareholder Vote Results (May 28, 2025)

DuPont de Nemours, Inc. held its Annual Meeting of Stockholders on May 22, 2025. Of the 418,498,498 shares of common stock outstanding and entitled to vote as of the March 31, 2025 record date, 339,910,658 shares were voted in person or by proxy, representing 81.22 percent of the shares entitled to be voted. The filing states that all matters voted on are described in the Company's 2025 Proxy Statement. Stockholders elected all 13 director nominees to serve until the next annual meeting or until their successors are duly elected and qualified. They also approved, on an advisory basis, the compensation of the named executive officers, with 257,257,815 votes for, 22,559,036 against, 2,555,889 abstaining, and 57,537,918 broker non-votes. Stockholders also ratified PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2025, with 336,941,794 votes for, 2,243,977 against, and 724,887 abstaining. The filing reports the voting outcomes only and includes no financial results or operating guidance. Investors seeking the Company's financial position or governance detail should refer to the 2025 Proxy Statement, which the filing cites for the matters voted on.

May 28, 2025 8-K

DuPont de Nemours 8-K Report, Corporate Update (May 2, 2025)

DuPont de Nemours, Inc. filed this Form 8-K to recast the segment information in its 2024 Form 10-K, changing its reportable segments from the prior structure to two segments, ElectronicsCo and IndustrialsCo, effective in the first quarter of 2025. The change reflects the planned separation of the Electronics business, which the company is targeting for completion on November 1, 2025, while it retains the Water business. Apart from the segment recast, the filing states that it does not update other developments since the 2024 Form 10-K, and it directs readers to the first-quarter 2025 Form 10-Q filed the same day for more current information. For 2024, the recast shows ElectronicsCo net sales of $4,336 million, up 7 percent from 2023, with Operating EBITDA of $1,372 million, up 19 percent. IndustrialsCo reported net sales of $8,050 million, flat compared with $8,034 million in 2023, and Operating EBITDA of $1,919 million, compared with $1,915 million in 2023. Consolidated net sales for 2024 were $12.4 billion, up 3 percent from $12.1 billion in 2023. The filing also restates balance sheet and capital items from the 2024 Form 10-K. At December 31, 2024, the company reported $1.9 billion of cash and cash equivalents and $7.2 billion of total debt. It stated that it does not plan to complete the remaining $500 million under its $1 billion share buyback program, which terminates June 30, 2025, and it expects 2025 capital expenditures of about $660 million, including separation-related spending.

May 2, 2025 8-K

DuPont de Nemours 8-K Report, Financial Results (May 2, 2025)

DuPont de Nemours, Inc. reported first quarter 2025 net sales of $3,066 million, up 5% from $2,931 million a year earlier, with organic sales up 6% on an 8% volume increase partly offset by a 2% decrease in price. Operating EBITDA rose 16% to $788 million, and the operating EBITDA margin widened to 25.7% from 23.3%. Adjusted EPS increased 30% to $1.03 from $0.79. ElectronicsCo led growth, with net sales up 14% and operating EBITDA up 26%, while IndustrialsCo net sales were flat and organic sales grew 2%. GAAP results were weak. The company recorded a $768 million non-cash goodwill impairment charge tied to the Aramids reporting unit, which was identified as a standalone reporting unit after the first quarter 2025 segment realignment. This drove a GAAP loss from continuing operations of $(548) million, or $(1.33) per share. Cash provided by operating activities from continuing operations was $382 million, compared with $493 million a year earlier, and transaction-adjusted free cash flow was $212 million after capital expenditures of $249 million and separation-related transaction cost payments of $79 million. Management maintained full year 2025 guidance of net sales of $12,800 million to $12,900 million, operating EBITDA of $3,325 million to $3,375 million, and adjusted EPS of $4.30 to $4.40. That guidance excludes an estimated net cost impact of about $60 million (about $0.10 per share) from announced tariffs. The company reaffirmed its target of November 1, 2025 for the spin-off of its Electronics business, which was announced as Qnity, and said it had filed the initial Form 10 registration statement with the SEC.

May 2, 2025 10-Q

DuPont de Nemours Quarterly Report for Q1 Ended Mar 31, 2025

DuPont de Nemours, Inc. reported a net loss available to common stockholders of $589 million, or $(1.41) per diluted share, for the three months ended March 31, 2025, compared with net income of $189 million, or $0.45 per diluted share, a year earlier. The swing was driven mainly by a non-cash goodwill impairment charge of $768 million tied to the Aramids reporting unit within the IndustrialsCo segment. Net sales rose to $3,066 million from $2,931 million, with the filing attributing the increase primarily to a 8 percent increase in volume, partially offset by a 2 percent decrease in local price and product mix. Loss from continuing operations before income taxes was $(429) million, compared with income of $267 million in the prior-year quarter. The quarter was shaped by the company's planned separation of its Electronics business, which DuPont is targeting for completion on November 1, 2025. The company realigned into two segments, ElectronicsCo and IndustrialsCo. ElectronicsCo net sales increased 14 percent to $1,118 million and segment Operating EBITDA rose to $373 million from $295 million, while IndustrialsCo net sales were flat at $1,948 million and Operating EBITDA increased to $464 million from $439 million. Acquisition, integration and separation costs were $125 million, mostly tied to the separation, and the company recorded $46 million of pre-tax charges under a Transformational Separation-Related Restructuring Program that it expects to total $100 million through 2026. Liquidity remained solid, with cash and cash equivalents of $1,762 million, total debt of $7,174 million, and working capital of $1.8 billion at March 31, 2025. Operating cash flow from continuing operations was $382 million, down from $493 million, and the company declared a second-quarter 2025 dividend of $0.41 per share. The filing also notes a $78 million non-cash interest rate swap gain within sundry income and ongoing PFAS-related litigation and indemnification exposures. The filing states that DuPont is evaluating the impact of tariffs and trade measures and that a Chinese regulatory investigation into its Tyvek business began in April 2025.

May 2, 2025 8-K

DuPont de Nemours 8-K Report, Regulation FD Disclosure (Apr 4, 2025)

DuPont de Nemours, Inc. (the "DuPont") disclosed in a Regulation FD Item 7.01 filing that it is aware of a report that the State Administration for Market Regulation of the People's Republic of China (SAMR) has initiated an investigation in connection with its Tyvek® business. The company states it takes the matter very seriously and is cooperating as appropriate with authorities. The filing provides a sizing of the exposure: DuPont Tyvek® sales to China in full year 2024 were approximately $90 million, which the company states is less than 1% of its 2024 consolidated net sales. The filing does not describe the scope of the investigation, any potential penalties, or any timeline for resolution. The information is furnished under Item 7.01 and is not deemed filed for purposes of Section 18 of the Securities Exchange Act, nor incorporated by reference into Securities Act or Exchange Act filings.

Apr 4, 2025 8-K

DuPont de Nemours 8-K Report, Executive Changes (Mar 17, 2025)

DuPont de Nemours, Inc. reported in an 8-K filed March 17, 2025 that Mr. Leland G. Weaver, President of the Water & Protection segment, will leave the Company effective upon completion of the separation of its electronics business into an independent, publicly traded company (the "Intended Electronics Separation"). This is a Item 5.02 disclosure covering a departure of an officer and related compensatory arrangements. Until a successor is named, Mr. Weaver will serve as President of the Diversified Solutions businesses. These include Shelter Solutions, Aramids, the retained Mobility & Materials businesses, and the former Industrial Solutions businesses of Printing & Packaging (including Spectrum Food & Industrial), Molykote®, and Vespel®. After the Intended Electronics Separation, he will work to ensure an orderly transition. The filing states that Mr. Weaver's departure will be a separation from service without cause under the DuPont Senior Executive Severance Plan, which is incorporated by reference to Exhibit 10.4 to a Form 8-K filed June 3, 2019. For investors, the key points are the leadership change tied to the electronics separation and the interim assignment of the Diversified Solutions businesses.

Mar 17, 2025 8-K

DuPont de Nemours 8-K Report, Executive Changes (Feb 21, 2025)

DuPont de Nemours, Inc. (NYSE: DD) announced on February 21, 2025 that it appointed Kurt B. McMaken to its Board of Directors, effective immediately. The Board determined that Mr. McMaken is an independent director under New York Stock Exchange listing standards, SEC rules, and the Company's Corporate Governance Guidelines, and that he meets the SEC's criteria of an audit committee financial expert. He will serve on the Audit Committee and the Nomination and Governance Committee. Mr. McMaken, 55, is currently Chief Financial Officer of The Brink's Company, a provider of cash and valuables management, digital retail solutions, and ATM managed services. Before joining Brink's in 2022, he held a series of financial and management roles of increasing responsibility at Eaton Corporation plc from 2001 to 2022, most recently as Senior Vice President, Operations Finance and Transformation. He began his career in the Audit & Business Advisory Services practice at PricewaterhouseCoopers LLP. He holds a B.S. from Georgetown University and an M.B.A. from the University of Chicago Booth School of Business. The filing states there is no arrangement or understanding under which Mr. McMaken was selected as a director, and no transactions requiring disclosure under Item 404(a) of Regulation S-K. He will receive the Company's standard compensation for non-employee directors. The announcement was made through a press release attached as Exhibit 99.1, in which DuPont's Executive Chairman Ed Breen praised his global manufacturing and finance expertise.

Feb 21, 2025 10-K

DuPont de Nemours Annual Report, Year Ended Dec 31, 2024

DuPont de Nemours, Inc. (NYSE: DD) reported 2024 net sales of $12.4 billion, up 3 percent from $12.1 billion in 2023, with income from continuing operations before income taxes of $1,192 million versus $504 million a year earlier. Electronics & Industrial net sales rose 11 percent to $5,930 million and Operating EBITDA rose 17 percent to $1,717 million, driven by semiconductor and interconnect volume recovery. Water & Protection net sales fell 4 percent to $5,423 million and Operating EBITDA fell 2 percent to $1,360 million. Net income available to common stockholders was $703 million, or $1.67 per diluted share, compared with $423 million in 2023. The central strategic event is the planned separation of the Electronics business, which DuPont is targeting for completion on November 1, 2025; DuPont will retain the Water business. The company also expects a 2025 segment realignment that will report the Electronics businesses as a single segment. Capital allocation has shifted: DuPont completed its $5 billion buyback program, repurchased shares under a $1 billion program, and stated it does not intend to use the remaining $500 million of that $1 billion authorization. Cash and cash equivalents were $1.9 billion at year-end, and total debt was $7.2 billion, down from $7.8 billion after a $650 million partial redemption of 2038 notes. Key risks flagged in the filing include the execution and tax treatment of the Electronics separation, continuing PFAS-related liabilities and indemnification obligations to Corteva and Chemours, and a goodwill carrying amount of $16.6 billion, with the Protection reporting unit's fair value exceeding its carrying value by approximately 5 percent. Credit ratings at January 31, 2024 were BBB+ (S&P, Watch Negative), Baa1 (Moody's, Negative) and BBB+ (Fitch, Watch Negative).

Feb 14, 2025 8-K

DuPont de Nemours 8-K Report, Financial Results (Feb 11, 2025)

DuPont de Nemours, Inc. reported fourth quarter and full year 2024 results on February 11, 2025, and initiated 2025 financial guidance, per a press release furnished as Exhibit 99.1. For the fourth quarter, net sales were $3,092 million, up 7%, with organic sales also up 7%. The company posted a GAAP loss from continuing operations of $(61) million, versus $(300) million a year earlier, and operating EBITDA of $807 million, up 13%. GAAP EPS from continuing operations was $(0.17), while adjusted EPS rose 30% to $1.13. For full year 2024, net sales were $12,386 million, up 3% (organic sales up 1%), GAAP income from continuing operations was $778 million, operating EBITDA was $3,144 million, and adjusted EPS was $4.07, up 17%. Cash provided by operating activities from continuing operations was $2,321 million, and transaction-adjusted free cash flow was $1,806 million. Management highlighted continued strength in electronics end-markets and a return to year-over-year top-line growth in Water & Protection in the fourth quarter. The company also reaffirmed progress on the intended separation of its Electronics business, which it is targeting for completion on November 1, 2025, while retaining the Water business. Effective in the first quarter of 2025, the company will realign its management and reporting structure, changing its reportable segments so that the businesses comprising the intended Electronics separation will be reported as a single segment. For 2025, DuPont guided to first quarter net sales of about $3,025 million, operating EBITDA of about $760 million, and adjusted EPS of about $0.95. For full year 2025, it guided to net sales of $12,800 million to $12,900 million, operating EBITDA of $3,325 million to $3,375 million, and adjusted EPS of $4.30 to $4.40. The guidance assumes mid-single digit organic growth and a foreign currency headwind of about 1% for the full year.

Feb 11, 2025 10-Q

DuPont de Nemours Quarterly Report for Q3 Ended Sep 30, 2024

DuPont de Nemours, Inc. reported third-quarter 2024 net sales of $3.19 billion, up from $3.06 billion a year earlier, driven by a 5 percent volume increase and a 2 percent increase from portfolio actions, partially offset by 2 percent declines in local price and product mix and 1 percent unfavorable currency impact. Income from continuing operations rose to $480 million from $291 million, and net income available for common stockholders was $454 million versus $319 million. Results were helped by a $191 million non-cash gain on interest rate swaps and a lower effective tax rate of 18.1 percent, which the filing attributes largely to discrete tax benefits including an international tax audit settlement. Operating EBITDA, the company's segment profit measure, was $857 million versus $775 million. Electronics & Industrial drove growth, with net sales up 13 percent on volume gains in Semiconductor Technologies and Interconnect Solutions, while Water & Protection net sales fell 2 percent. For the nine months ended September 30, 2024, net sales were approximately $9.3 billion, up 1 percent, and cash provided by continuing operations was $1,757 million versus $1,545 million. Cash and cash equivalents fell to $1,645 million from $2,392 million at year-end 2023, and long-term debt declined to $7,170 million from $7,800 million after a $650 million partial redemption of 2038 notes. The company completed its $5 billion share buyback program in the first quarter of 2024 and has $500 million remaining under a $1 billion program that it stated it does not currently plan to complete, given its focus on the Intended Business Separations announced May 22, 2024, which would split the company into three independent public companies. The filing also discloses ongoing PFAS-related liabilities, with the company's share of the Water District Settlement Fund contribution of $400 million paid in 2023 and an accrued total of $226 million for MOU-related indemnification liabilities. The filing notes credit ratings of BBB+ at S&P and Fitch and Baa1 at Moody's, with S&P and Fitch on watch negative and Moody's outlook negative following the separation announcement. Management stated the company has sufficient liquidity, with $3.6 billion of working capital and a current ratio of 2.28:1.

Nov 5, 2024 8-K

DuPont de Nemours 8-K Report, Financial Results (Nov 5, 2024)

DuPont de Nemours, Inc. reported third quarter 2024 results for the period ended September 30, 2024, as stated in a press release furnished as Exhibit 99.1 to this Form 8-K. Net sales were $3,192 million, up 4% from $3,058 million a year earlier, with organic sales growth of 3%, a favorable portfolio impact of 2%, and a 1% currency headwind. GAAP income from continuing operations rose to $480 million from $291 million, GAAP EPS from continuing operations was $1.13 versus $0.62, and adjusted EPS was $1.18 versus $0.92. Operating EBITDA was $857 million, up 11%, with operating EBITDA margin expanding 150 basis points to 26.8%. Cash provided by operating activities from continuing operations was $737 million, and transaction-adjusted free cash flow was $640 million. By segment, Electronics & Industrial net sales rose 13% with 10% organic growth, driven by semiconductor and interconnect recovery, while Water & Protection net sales fell 2%, with organic sales down 2% on lower price. The company raised its full-year 2024 guidance for operating EBITDA to about $3,125 million (from $3,060-$3,110 million) and adjusted EPS to about $3.90 (from $3.70-$3.80), and full-year net sales guidance is now about $12,365 million (from $12,400-$12,500 million). Management continues to pursue the previously announced separation of the Electronics and Water businesses from the company, which will leave DuPont as a diversified industrial company. The filing also notes the company's $1 billion share repurchase program announced February 6, 2024, which runs through June 30, 2025. The results are furnished under Item 2.02 and are not deemed filed for Section 18 purposes.

Nov 5, 2024 10-Q

DuPont de Nemours Quarterly Report for Q2 Ended Jun 30, 2024

DuPont de Nemours, Inc. reported second-quarter 2024 net sales of $3.2 billion, up 2 percent from $3.1 billion a year earlier, driven by a 4 percent increase from portfolio actions (the Spectrum acquisition) and a 2 percent increase in volume, partly offset by 2 percent declines in local price and product mix and currency. Net income available to common stockholders was $178 million, compared with a loss of $131 million in the prior-year quarter, which included discontinued operations. Income from continuing operations fell to $176 million from $269 million, and diluted earnings per share from continuing operations were $0.40 versus $0.55. Sundry expense of $87 million included a $74 million loss on early debt redemption and a $39 million interest rate swap mark-to-market loss. The effective tax rate on continuing operations was 40.5 percent for the quarter. Segment performance diverged. Electronics & Industrial net sales rose 15 percent to $1.51 billion, with volume up 10 percent, led by Semiconductor Technologies and Interconnect Solutions, and Operating EBITDA increased 20 percent to $419 million. Water & Protection net sales fell 7 percent to $1.39 billion on a 4 percent volume decline, reflecting customer destocking, and Operating EBITDA declined 7 percent to $344 million. For the six months, net sales were flat at $6.10 billion, and cash provided by continuing operating activities was $1.02 billion. Balance sheet and capital allocation were central to the period. Cash and cash equivalents declined to $1.50 billion from $2.39 billion, and total debt decreased to $7.17 billion after a $650 million partial redemption of 2038 notes. Discontinued operations used $439 million in the first half, including a $408 million contribution tied to the Water District PFAS settlement, which became final in the second quarter. On May 22, 2024, DuPont announced plans to separate into three independent companies through the separation of its Electronics and Water businesses, expected within 18 to 24 months. Standard & Poor's and Fitch placed the company on negative credit watch, and Moody's revised its outlook to negative. The company also disclosed ongoing PFAS-related exposure, though it stated that it cannot estimate losses above amounts accrued.

Jul 31, 2024 8-K

DuPont de Nemours 8-K Report, Financial Results (Jul 31, 2024)

DuPont de Nemours, Inc. reported second-quarter 2024 results on July 31, 2024, in a press release furnished as Exhibit 99.1. Net sales were $3,171 million, up 2% from $3,094 million a year earlier, with organic sales flat as a 2% volume increase was offset by a 2% price decrease. Portfolio impact of 4%, mainly from the August 2023 Spectrum acquisition, was partly offset by a 2% currency headwind. GAAP income from continuing operations was $176 million, down from $269 million, and GAAP EPS from continuing operations was $0.40, versus $0.55. Operating EBITDA rose 8% to $798 million, with an operating EBITDA margin of 25.2% compared with 23.9%. Adjusted EPS was $0.97, a 14% year-over-year increase. Cash provided by operating activities from continuing operations was $527 million, up 32%, and adjusted free cash flow was $425 million, up 53%. Electronics & Industrial net sales rose 15% (8% organic), driven by semiconductor, AI-related and interconnect recovery. Water & Protection net sales fell 7% (6% organic), reflecting destocking in medical packaging and in Chinese water distribution. For full-year 2024, DuPont raised guidance for net sales to $12,400 million to $12,500 million, operating EBITDA to $3,060 million to $3,110 million, and adjusted EPS to $3.70 to $3.80. Management expects a return to year-over-year organic sales growth in the third quarter. The filing also highlights the planned separation of the Electronics and Water businesses, announced May 22, 2024, which DuPont expects to complete within 18 to 24 months as a tax-free transaction. Results were affected by a $74 million loss on debt extinguishment and a $39 million interest rate swap mark-to-market loss, both recorded in sundry income (expense). The company also noted the closing of the Donatelle acquisition and a $1 billion share repurchase program announced February 6, 2024, which runs until June 30, 2025.

Jul 31, 2024 8-K

DuPont de Nemours 8-K Report, Executive Changes (Jun 27, 2024)

DuPont de Nemours, Inc. filed this Form 8-K on June 27, 2024 under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). The filing reports that, effective June 27, 2024, the Board of Directors appointed Lori D. Koch, the Company's Chief Executive Officer, to the Board. The filing states that Ms. Koch has served as Chief Executive Officer since June 1, 2024, and previously served as Chief Financial Officer since February 2020. Before that, she was Vice President, Investor Relations and Corporate Financial Planning & Analysis from June 2019, and held finance and investor relations roles at E. I. du Pont de Nemours and Company ("EIDP") from April 2008 onward. The filing states that Ms. Koch has not been appointed to, and is not expected to join, any Board committees, and that she will receive no additional compensation for her Board service. It also states that she has no family relationship with any director or executive officer, no arrangement or understanding under which she was selected as a director, and no material interest in any related-person transaction under Item 404(a) of Regulation S-K. She currently serves as a director of Actylis, a New Mountain Capital LLC portfolio company, and is on the Board of Visitors of the Smeal College of Business at Penn State University. For investors, the principal item is the leadership change: the CEO now also sits on the Board, and the filing describes her as having moved from CFO to CEO effective June 1, 2024. The filing does not include financial results, guidance, or compensation terms for the CEO role.

Jun 27, 2024 8-K

DuPont de Nemours 8-K Report, Shareholder Vote Results (Jun 7, 2024)

DuPont de Nemours, Inc. commenced its Annual Meeting of Stockholders on May 23, 2024, adjourned it, and reconvened on June 5, 2024. As of the March 28, 2024 record date, 418,074,174 shares of common stock were outstanding and entitled to vote. A total of 347,200,998 shares, representing 83.05 percent of the shares entitled to be voted, were cast in person or by proxy. Stockholders elected all 12 director nominees and approved, on an advisory basis, the compensation of the named executive officers, with 237,752,407 votes for and 50,062,441 against. Stockholders also ratified PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2024, with 345,553,114 votes for. The Board determined to continue holding an annual advisory vote on executive compensation, consistent with the one-year frequency that received 282,149,037 votes. James A. Lico was elected to the Board and appointed to the People and Compensation Committee and the Environment, Health, Safety & Sustainability Committee effective on the date of his election. Stockholders did not approve a stockholder proposal to amend the Company's Incentive Compensation Clawback Policy, which received 21,846,529 votes for and 264,318,802 against. The filing also includes the cover page of the Form 8-K in Inline XBRL as Exhibit 104.

Jun 7, 2024